Showing 4,841 - 4,860 results of 64,281 for search '(( 50 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 2 e decrease ))', query time: 1.46s Refine Results
  1. 4841
  2. 4842
  3. 4843

    DNL in HepG2 following E4orf1 transfection. by Emily J. Dhurandhar (302102)

    Published 2013
    “…A) Expressed as mean fold change in pmol [<sup>14</sup>-C]-glucose/mg protein relative to null, ± SD. Two separate experiments were combined. E4orf1 significantly decreases DNL compared to null (p = 0.01). …”
  4. 4844
  5. 4845

    LIF and BMP4 regulate eIF2α phosphorylation and translation initiation. by Kyle Friend (799951)

    Published 2015
    “…LIF signals to phosphorylate eIF4G via an unknown pathway. CReP loss and PKR activation increase P-eIF2α levels.…”
  6. 4846

    Reliability of the competitive RT-PCR assay for CYP2E1 transcript by Ania Mendoza-Cantú (16382)

    Published 2011
    “…The expected PCR products of 453 and 382 bp correspond to endogenous CYP2E1 mRNA and recRNA, respectively. () A fixed amount of recRNA (1 pg) was incubated with decreasing amounts of human lymphocyte total RNA. …”
  7. 4847

    Transfer of plaques to a normolipidemic plasma environment decreases their size and reduces their burden of CD68+ cells and cholesteryl esters. by Jonathan E. Feig (155406)

    Published 2012
    “…<p>Transplantation experiments were performed as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0039790#s2" target="_blank">Methods</a>. Reversal of dyslipidemia (WT recipient) decreases plaque size (A) and CD68+ cell content (B) but continued dyslipidemia (apoE−/−) does not. …”
  8. 4848

    eGFP expression increased after 5-Aza-2′-Deoxycytidine treatment. by Andrea Luchetti (183589)

    Published 2012
    “…<p>A) Bright field (upper row) and fluorescent (bottom row) images of D1 sorted corrected cells at different experimental time (scale bar: 150 µm). B) eGFP expression, analyzed by Real Time PCR, after 24 h and 48 h of treatment with 0.5 µM 5-Aza-2′-Deoxycytidine respect to untreated (0 h) (*p = 0.002); untreated cells, at 24 h and 48 h, usually showed a decreasing relative eGFP expression (data not shown).…”
  9. 4849
  10. 4850
  11. 4851
  12. 4852
  13. 4853
  14. 4854

    ANOVA for vigor index A. by Ahad Asghari (20615202)

    Published 2025
    “…The results revealed that increasing PAW levels up to 0.18 min/mL led to an increase in seed germination percentage, seedling weight (both fresh and dry), seedling length, vigor indexes A and B, and water uptake and decreasing mean germination time. …”
  15. 4855

    Overexpression of E2F1 led to the proliferation of the tumor cells in vitro. by Xin Ma (37268)

    Published 2013
    “…(C) MTS assay showed E2F1 overexpression accelerated the proliferation velocity in 786-O and A498 cells and knockdown of E2F1 in Caki-1 decreased the proliferation. …”
  16. 4856

    Effects of E2F1 on the abilities of in vitro cell motility and migration. by Xin Ma (37268)

    Published 2013
    “…(C) In Caki-1 cells E2F1 knockdown markedly decreased the cell viability (<i>p</i>=0.002). …”
  17. 4857

    E2 increases the apoptosis of n-3 PUFA-treated BCa cells. by WenQing Cao (107805)

    Published 2012
    “…Percentages of TUNEL-positive cells were counted. <b>C</b>, E2 decreased Bcl2 expression in MCF-7 cells that were treated with DHA or EPA (90 µM) (n = 3). …”
  18. 4858
  19. 4859
  20. 4860